M. R. Spitz

Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis.

M. Spitz, W. Hong, Q. Wei, 2000, Carcinogenesis.

Mutagen sensitivity: a biological marker of cancer susceptibility.

M. Spitz, T. Hsu, S. Schantz, 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers.

Diane D. Liu, M. Spitz, R. Lotan, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Three measures of mutagen sensitivity in a cancer-free population.

M. Spitz, A. Sigurdson, T. Hsu, 1999, Cancer genetics and cytogenetics.

Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer.

M. Spitz, Z. F. Zhang, T. Hsu, 1999, Cancer letters.

Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.

M. Spitz, S. Singletary, M. Bondy, 2001, Cancer research.

A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases.

M. Spitz, C. Amos, J. Annegers, 1995, Cancer research.

A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay.

M. Spitz, W. Hong, J. Lee, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Molecular dosimeters of smoking damage in the lung.

M. Spitz, M. Andrade, J. Di Giovanni, 1999, Journal of the National Cancer Institute.

DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines.

M. Spitz, T. Hsu, S. Strom, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer.

Edward S. Kim, M. Spitz, S. Lippman, 2010, Carcinogenesis.